Oracle Life Sciences Data Intelligence — AI with 122M Patient Records for Pharma Research
ENTITYOracle is deepening its life sciences push with AI agents and real-world data analytics capabilities, according to Fierce Healthcare. The company's Life Sciences Data Intelligence platform is reported to include access to approximately 122 million patient records, positioning Oracle as a major player in the real-world evidence market for pharmaceutical research. The combination of AI agents and large-scale real-world data is designed to accelerate pharmaceutical research workflows, including clinical trial design, patient cohort identification, safety signal detection, and regulatory evidence generation. Oracle's scale in patient data gives it a competitive advantage over smaller real-world data vendors. The expansion reflects Oracle's strategy of leveraging its healthcare data assets — built through its acquisition of Cerner and other health IT investments — to capture value in the pharmaceutical and life sciences market, where real-world data is increasingly central to drug development and regulatory submissions. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.